Advances in AIDS chemotherapy: The asymmetric synthesis of CRIXIVAN®

Research output: Contribution to journalArticlepeer-review

42 Scopus citations


The discovery and development of an efficient, practical asymmetric synthesis of the HIV Protease inhibitor CRIXIVAN® is described. Particular emphasis is placed on the selective installation of each of the five stereogenic centers as well as design strategies associated with the preparation of a complex pharmaceutical agent needed in multiton quantities.

Original languageEnglish (US)
Pages (from-to)306-308
Number of pages3
Issue number6
StatePublished - 1997
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • General Chemistry


Dive into the research topics of 'Advances in AIDS chemotherapy: The asymmetric synthesis of CRIXIVAN®'. Together they form a unique fingerprint.

Cite this